Peter is a scientist, educator and entrepreneur with a career long commitment in personalized medicine and individualized cancer patient care. He is focused on the redesign of cancer care. The first product from technology developed by Dr. Kuhn became available for prostate cancer care in June 2016. Dr. Kuhn’s strategy is to advance our understanding of the human body to improve the human condition for those affected by cancer. His research is shedding new light at how cancer spreads through the body and evolves over time. This new science leads to a personalized care strategy that is biologically informed and clinically actionable. Dr. Kuhn has published over 300 peer reviewed manuscripts and his work has been cited over 22k times. His research has resulted in the creation of multiple companies including Epic Sciences and Cansera.
Track Chair: Hakan Sakul, Pfizer